Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Meeting report of the third Heidelberg myeloma workshop: current status and developments in diagnosis and therapy of multiple myeloma

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

Conflict of interest

None.

Author information

Correspondence to Jens Hillengaß.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hillengaß, J., Neben, K. & Goldschmidt, H. Meeting report of the third Heidelberg myeloma workshop: current status and developments in diagnosis and therapy of multiple myeloma. J Cancer Res Clin Oncol 138, 173–178 (2012). https://doi.org/10.1007/s00432-011-1071-4

Download citation

Keywords

  • Multiple Myeloma
  • Myeloma
  • Thalidomide
  • Bortezomib
  • Zoledronic Acid